Gulf International Bank (Uk) LTD Novo Cure LTD Transaction History

Gulf International Bank (Uk) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$40.29 - $82.51 $115,027 - $235,566	-2,855 Reduced 22.85%	9,637 $399,000
Q1 2023 Apr 12, 2023	SELL	$56.44 - $118.81 $245,514 - $516,823	-4,350 Reduced 25.83%	12,492 $751,000
Q4 2021 Jan 24, 2022	SELL	$75.08 - $121.99 $300,320 - $487,960	-4,000 Reduced 19.19%	16,842 $1.26 Million
Q2 2021 Aug 10, 2021	BUY	$130.4 - $225.58 $127,792 - $221,068	980 Added 4.93%	20,842 $4.62 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $272,297 - $417,232	-2,194 Reduced 9.95%	19,862 $2.63 Million
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $2.47 Million - $3.84 Million	22,056 New	22,056 $3.82 Million

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.